【レポートの概要（一部）】
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
• Key buying criteria
PART 05: Cardiovascular drugs market
• Global pharmaceuticals market
• Global cardiovascular drugs market
PART 06: Overview: Hypertension
• Systemic hypertension
• PAH
PART 07: Epidemiology and economic burden
• Economic burden
PART 08: Pipeline portfolio
PART 09: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 10: Market segmentation by type
• Global systemic hypertension drugs market
• Global PAH drugs market
PART 11: Market segmentation by drug class
• Systemic hypertension
• PAH
PART 12: Geographical segmentation
• Global hypertension drugs market by geographical segmentation 2015-2020
• Hypertension drugs market in Americas
• Hypertension drugs market in EMEA
• Hypertension drugs market in APAC
PART 13: Market drivers
• Growing older population
• Rise in sedentary lifestyle
• High prevalence of chronic conditions
• Patient assistance programs
PART 14: Impact of drivers
PART 15: Market challenges
• Patent expiries of major drugs
• Adverse effects
• Poor patient compliance
• Availability of alternative therapies
PART 16: Impact of drivers and challenges
PART 17: Market trends
• Increase in awareness
• Increased focus on combination therapies
• Intense competition among vendors
• Strategic alliances
PART 18: Vendor landscape
• Competitive scenario
• Market share 2015
• Novartis
• Daiichi Sankyo
• Actelion Pharmaceuticals
• Boehringer Ingelheim
• Sanofi
• AstraZeneca
• Other prominent vendors
PART 19: Appendix
• List of abbreviations
PART 20: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Key buying criteria for drugs that treat hypertension
Exhibit 03: Patent expiries of major cardiovascular drugs
Exhibit 04: Global cardiovascular drugs market by generic and branded drugs sales 2015
Exhibit 05: Top 10 companies in global cardiovascular drugs market 2014
Exhibit 06: Pathophysiology of hypertension
Exhibit 07: Treatment algorithm for hypertension
Exhibit 08: Prevalence of PAH by cause
Exhibit 09: Projected prevalence of CVDs in US 2010-2030 (% of population)
Exhibit 10: Prevalence of hypertension in US population 2010-2030 (% of population)
Exhibit 11: Projected direct and indirect burden of hypertension in US 2010-2030 ($ billions)
Exhibit 12: Projected mortality trend for CVDs globally 2015 and 2030
Exhibit 13: Pipeline portfolio: Global systemic hypertension drugs
Exhibit 14: Pipeline portfolio: Global PAH drugs
Exhibit 15: Market share of global hypertension drugs in global pharmaceutical market 2015
Exhibit 16: Global hypertension drugs market 2015-2020 ($ billions)
Exhibit 17: Five forces analysis
Exhibit 18: Global hypertension drugs market segmentation by type 2015
Exhibit 19: Global systemic hypertension drugs market 2015-2020 ($ billions)
Exhibit 20: Global PAH drugs market 2015-2020 ($ billions)
Exhibit 21: Segmentation of global hypertension drugs market by drug class
Exhibit 22: Global systemic hypertension drugs market share by drug class 2015
Exhibit 23: Global PAH drugs market share by drug class 2015
Exhibit 24: Segmentation of global hypertension drugs market based on geography 2015
Exhibit 25: Hypertension drugs market revenue by geography 2015-2020 ($ billions)
Exhibit 26: Percentage share of hypertension drugs market by geography 2015-2020
Exhibit 27: Hypertension drugs market in Americas 2015-2020 ($ billions)
Exhibit 28: Hypertension drugs market in EMEA 2015-2020 ($ billions)
Exhibit 29: Hypertension drugs market in APAC 2015-2020 ($ billions)
Exhibit 30: Global hypertension drugs market: YoY growth rate and revenue based on geography 2015-2020
Exhibit 31: Population aged 60 years and over: World, developed, and developing regions ($ millions)
Exhibit 32: Impact of drivers
Exhibit 33: Impact of drivers and challenges
Exhibit 34: Sales of major drugs in global hypertension drugs market 2014 ($ billions)
Exhibit 35: Novartis: YoY growth rate and revenue of Diovan 2012-2015 ($ billions)
Exhibit 36: Novartis: YoY growth rate and revenue of Exforge 2012-2015 ($ billions)
Exhibit 37: Novartis: Key takeaways
Exhibit 38: Daiichi Sankyo: YoY growth rate and revenue of Olmetec in Japan 2012-2014 ($ millions)
Exhibit 39: Daiichi Sankyo: YoY growth rate and revenue of Olmetec/Olmetec Plus in Europe 2012-2014 ($ millions)
Exhibit 40: Daiichi Sankyo: YoY growth rate and revenue of Rezaltas in Japan 2012-2014 ($ millions)
Exhibit 41: Daiichi Sankyo: YoY growth rate and revenue of Artist in Japan 2012-2014 ($ millions)
Exhibit 42: Daiichi Sankyo: YoY growth rate and revenue of Benicar/Benicar HCT in US 2012-2014 ($ millions)
Exhibit 43: Daiichi Sankyo: YoY growth rate and revenue of AZOR in US 2012-2014 ($ millions)
Exhibit 44: Daiichi Sankyo: YoY growth rate and revenue of TRIBENZOR in US 2012-2014 ($ millions)
Exhibit 45: Daiichi Sankyo: YoY growth rate and revenue of Sevikar in Europe 2012-2014 ($ millions)
Exhibit 46: Daiichi Sankyo: YoY growth rate and revenue of Sevikar HCT in Europe 2012-2014 ($ millions)
Exhibit 47: Daiichi Sankyo: Key takeaways
Exhibit 48: Actelion Pharmaceuticals: YoY growth rate and revenue of Tracleer 2011-2014 ($ billions)
Exhibit 49: Actelion Pharmaceuticals: YoY revenue of Opsumit 2013 and 2014 ($ millions)
Exhibit 50: Actelion Pharmaceuticals: YoY growth rate and revenue of Ventavis 2011-2014 ($ millions)
Exhibit 51: Actelion Pharmaceuticals: YoY growth rate and revenue of Veletri 2011-2014 ($ millions)
Exhibit 52: Actelion Pharmaceuticals: Key takeaways
Exhibit 53: Boehringer Ingelheim: YoY growth rate and revenue of Micardis 2012-2014 ($ millions)
Exhibit 54: Boehringer Ingelheim: Key takeaways
Exhibit 55: Sanofi: YoY growth rate and revenue of Aprovel 2012-2014 ($ millions)
Exhibit 56: Sanofi: YoY growth rate and revenue of Tritace 2012-2014 ($ millions)
Exhibit 57: Sanofi: YoY growth rate and revenue of Lasix 2012-2014 ($ millions)
Exhibit 58: Sanofi: Key takeaways
Exhibit 59: AstraZeneca: Business segmentation by revenue 2015
Exhibit 60: AstraZeneca: YoY growth rate and revenue of Seloken/Toprol 2013-2015 ($ millions)
Exhibit 61: AstraZeneca: YoY growth rate and revenue of Atacand 2013-2015 ($ millions)
Exhibit 62: AstraZeneca: YoY growth rate and revenue of Tenormin 2012-2014 ($ millions)
Exhibit 63: AstraZeneca: Key takeaways
【レポート販売概要】
■ タイトル：高血圧治療薬の世界市場2016-2020■ 英文：Global Hypertension Drugs Market 2016-2020
■ 発行日：2016年4月13日
■ 調査会社：Technavio
■ 商品コード：IRTNTR9233
■ 調査対象地域：グローバル
- 自動車塗装用接着剤・シーラントの世界市場2016-2020About Automotive Coatings Automotive coatings are products that enhance the exterior appearance and durability of a vehicle by protecting it from harsh external factors such as UV radiation, heat and cold, and grit from the road. Automotive adhesives and sealants are bonding agents with similar chemical constitutions and different functionalities. Adhesives are primarily used to provide structural …
- 鍛造の世界市場2016-2020Technavio predicts the global forging market to exhibit a healthy CAGR of around 8% during the forecast period. Forging is an appropriate substitution to the casting methodology as it ensures greater efficiency, reliability, and precision. Custom forging accounts for the largest segment. In North America, this segment achieves sales figures worth $6 billion annually. Some of the major end-users of …
- 前立腺がん治療薬開発の世界市場：ファーストインクラス革新の特定と商業化Frontier Pharma: Prostate Cancer - Identifying and Commercializing First-in-Class Innovation Summary Exceptionally Large and Innovative Pipeline The prostate cancer pipeline is among the largest in the pharmaceutical industry with 484 products in active development across all stages. The range of mechanisms of action employed by these compounds is also highly diverse, especially in comparison to t …
- 北米の能動防火（AFP）＆受動防火（PFP）システム市場分析・予測The North American active fire protection systems market is expected to grow at a CAGR of 7.0% from 2015 to 2020. The fire protection systems market has been segmented in terms of components and services. Fire protection is a practice of uninterrupted risk management through which risks to public and private infrastructures can be predicted and reduced. The North American fire protection systems m …
- 心臓モニタリング及び診断装置（医療機器）のグローバル市場（2012-2018）The Cardiac Monitoring and Diagnostic Devices market is expected to reach US$2.3 billion by 2017 primarily supported by the segments: types - Telemetry Systems, ECG Devices and Holter Monitor. Globally, Event Monitors and ECG Devices together account for approximately 33% of the market are expected to support the Cardiovascular Devices industry going forward. Geographical analysis shows that the h …
- 鉄鋼製品の世界市場About Steel Mills Products Market Steel mills have been at the forefront in the growth of the steel economy with end industries ranging from Automotive, Infrastructure and Construction and Industrial Manufacturing. The finished products ranges from cast steel billets to rolled steel. The current utilization rate of the existing global steel mills products is estimated to be 80 percent. Excess prod …
- 電着塗装の世界市場：陰極エポキシ塗料、陰極アクリル塗料、陽極エポキシ塗料、陽極アクリル塗料The report covers the e-coat market and further segments the market on the basis of type, application, and region. The market data for these types is given with respect to volume (Million Square Meter) and value (USD million). The market size, in terms of value, of e-coat is estimated to be USD 2.87 billion in 2015 and is projected to register a CAGR of about 5.12% between 2015 and 2020. The data …
- モバイルペットケアの世界市場：ペット美容、獣医医療About Mobile Pet Care The mobile pet grooming segment accounts for the major share of the market. The demand for grooming services is high as pet owners are enrolling their pets in pet grooming shows such as Groom Expo and Atlanta Pet Fair & Conference. Mobile pet grooming services are used regularly to maintain the appearance and hygiene of the pet. Technavio’s analysts forecast the global mobile …
- Malaria：医療検査市場2014The report presents a detailed analysis of the Malaria diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Malaria definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Commerci …
- オートバイ用イモビライザーの世界市場2017-2021About Motorcycle ImmobilizerAn immobilizer is an electronic security device that is used to prevent theft of motorcycles. Based on application, the motorcycle immobilizer market has been categorized into cruiser bikes, sports bikes, and commuter bikes. Technavio’s analysts forecast the global motorcycle immobilizer market to grow at a CAGR of 7.60% during the period 2017-2021. [Covered in this rep …
- カナダの病院用品市場（～2021）Canada Hospital Supplies Market Outlook to 2021 - Disposable Hospital Supplies, Mobility Aids and Transportation Equipment, Operating Room Equipment, Patient Examination Devices, Sterilization Equipment and Syringes and Needles Summary GlobalData’s new report, "Canada Hospital Supplies Market Outlook to 2021 - Disposable Hospital Supplies, Mobility Aids and Transportation Equipment, Operating Room …
- French Hospital Tumor Marker Testing Market 2014This new report from Venture Planning Group contains 533 pages, 43 tables, and presents a comprehensive analysis of the French hospital tumor marker testing market, including: Major issues pertaining to the French hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. Morta …
- RAIDコントローラ・カードの世界市場2016-2020About RAID Controller Cards RAID controller cards are used to improve performance and capacity by virtualizing independent, multiple hard disk drives (HDDs) into one or more arrays. The type of RAID arrays and the number and size of the disk drives determine the total array capacity. The total array capacity is independent of whether a software or hardware RAID controller card is used. Technavio’s …
- クラウドサービス仲介および実施可能要件の世界市場予測（～2021）The cloud services brokerage and enablement market is expected to grow from USD 7.44 Billion in 2016 to USD 26.71 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of 29.1% during the forecast period. Rapid adoption of hybrid cloud technologies, avoiding vendor lock-in, effective enterprise cost saving, and increasing demand for single point cloud services access are the major drivers of th …
- 麻酔モニタリング装置の世界市場The global anesthesia monitoring devices market is mainly driven by increase in the number of surgeries. The market value of anesthesia monitoring devices market was $414 million in 2012 and is expected to be $618 million by 2020, at a CAGR of 6.80%. The report “Global Anesthesia Monitoring Devices Market Forecast, 2012-2020”, analyzes the market into two types of monitors such as portable and sta …
